<code id='3B4D289E38'></code><style id='3B4D289E38'></style>
    • <acronym id='3B4D289E38'></acronym>
      <center id='3B4D289E38'><center id='3B4D289E38'><tfoot id='3B4D289E38'></tfoot></center><abbr id='3B4D289E38'><dir id='3B4D289E38'><tfoot id='3B4D289E38'></tfoot><noframes id='3B4D289E38'>

    • <optgroup id='3B4D289E38'><strike id='3B4D289E38'><sup id='3B4D289E38'></sup></strike><code id='3B4D289E38'></code></optgroup>
        1. <b id='3B4D289E38'><label id='3B4D289E38'><select id='3B4D289E38'><dt id='3B4D289E38'><span id='3B4D289E38'></span></dt></select></label></b><u id='3B4D289E38'></u>
          <i id='3B4D289E38'><strike id='3B4D289E38'><tt id='3B4D289E38'><pre id='3B4D289E38'></pre></tt></strike></i>

          hotspot

          hotspot

          author:focus    Page View:116
          Miniature people figurines standing in a group looking down. -- health tech coverage from STAT
          Adobe

          In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

          Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

          advertisement

          Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Drugmakers bet big on mRNA for cancer. Why's Biden going in?
          Drugmakers bet big on mRNA for cancer. Why's Biden going in?

          DrugmakersalreadybetbigonmRNAforcancer.NowPresidentBidenisgoingin,too?AnnaMoneymaker/GettyImagesWASH

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          DeSantis wants to import drugs. Biden’s FDA blasted his plan

          FloridaGov.andGOPpresidentialcandidateRonDeSantiswantstoimportCanadianprescriptiondrugs.CharlieNeibe